Omuyambi: Traditional healer support to improve HIV viral suppression in rural Uganda
Omuyambi:传统治疗师支持改善乌干达农村地区的艾滋病病毒抑制
基本信息
- 批准号:10619333
- 负责人:
- 金额:$ 67.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-15 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAdherenceAdultAffectAfricaAfrica South of the SaharaAfricanBenchmarkingBloodCaringCessation of lifeClientClinicClinicalClinical TrialsCluster randomized trialCommunitiesConsolidated Framework for Implementation ResearchContinuity of Patient CareCounselingDataDrynessEffectivenessEnrollmentEpidemicFosteringGoalsGuidelinesHIVHIV InfectionsHIV SeropositivityHIV-1HairHealthHealthcareHuman immunodeficiency virus testHybridsIndividualInfectionInterventionLinkMaintenanceMeasuresMethodsMissionMorbidity - disease rateNamesNational Institute of Mental HealthNewly DiagnosedOutcomeParticipantPersonsPilot ProjectsProviderRNARandomizedRecommendationReportingResearchResearch DesignResearch SupportResource AllocationResourcesRuralRural CommunityRural PopulationService delivery modelSiteSpottingsSystemTenofovirTest ResultTestingTrainingTrustUgandaUnited States National Institutes of HealthViralViral Load resultWorld Health Organizationarmclinical careeffectiveness evaluationeffectiveness/implementation trialevidence basefollow-upglobal healthhealth goalsimplementation determinantsimplementation evaluationimplementation outcomesimplementation/effectivenessimprovedinnovationintervention deliverymembermenmortalitynovelprimary outcomeprogramsprovider interventionpsychosocialrandomized, clinical trialsrecruitresource guidessecondary outcomeself testingtesting uptaketransmission processtreatment armuptake
项目摘要
PROJECT SUMMARY AND ABSTRACT
People living with HIV (PLWH) in rural sub-Saharan Africa are three times less likely to achieve viral
suppression than their urban counterparts. Novel HIV service delivery models for rural PLWH are needed to
improve the HIV continuum of care and achieve viral suppression. Traditional healers (TH) are lay providers
who serve as the first line of healthcare in rural Africa, and frequently provide care to PLWH who have
disengaged from HIV care. TH are accessible, trusted members of rural communities, but have not been
integrated into HIV care programs. Our prior cluster randomized trial demonstrated that partnerships with TH
quadrupled the uptake of HIV testing in rural Uganda through facilitation of HIV counseling and self-testing.
Building on these results, we adapted an evidence-based lay provider intervention for delivery by Ugandan TH
to support subsequent steps of the HIV continuum. The TH-delivered program is called Omuyambi (“Support”
in Runyankole) and includes assisting PLWH to link to care for ART initiation, providing ongoing counseling on
ART adherence, and encouraging retention in clinical care. We conducted a pilot study of this lay provider
program among 12 TH and 20 PLWH who were disengaged from HIV care or ART naïve. Results were
overwhelmingly positive: 100% of PLWH linked to HIV care and initiated ART within 14 days, 95% reported
ART adherence and 100% were retained in care after nine months. Building upon this evidence, we
hypothesize that TH can support clinic-based care and improve viral suppression among rural PLWH. We
will conduct a hybrid type I effectiveness-implementation cluster randomized trial to evaluate the effectiveness
of the Omuyambi intervention on viral suppression among ART naïve/defaulted PLWH in Uganda.
• Aim 1: Compare the Omuyambi intervention versus routine HIV clinic-based care (control) in a cluster
randomized trial. Forty TH clusters that include ≥650 PLWH will be randomized to the Omuyambi intervention
or to a control arm, in which TH will refer PLWH to clinic-based HIV care alone. Primary clinical outcome is
viral suppression at 12 months measured via dried blood spot analysis. We hypothesize that 80% of PLWH in
the intervention arm will achieve viral suppression, compared with 60% in the control arm.
• Aim 2: Evaluate implementation of Omuyambi using a convergent mixed methods study design and the
Consolidated Framework for Implementation Research (CFIR). Qualitative and quantitative data will be
collected from participating TH, PLWH, HIV clinic staff, and Ministry of Health Officials. These data will be used
to assess Omuyambi implementation determinants and outcomes.
The proposed research is significant as it responds to the World Health Organization and Ugandan Ministry of
Health calls for community-based interventions to improve HIV viral suppression where current programs
have suboptimal impact. If effective, this approach has the potential to improve the HIV continuum among rural
PLWH towards UNAIDS 95-95-95 benchmarks necessary to end the HIV epidemic.
项目概要和摘要
撒哈拉以南非洲农村地区的艾滋病毒感染者 (PLWH) 感染病毒的可能性低三倍
压制程度高于城市同行。需要为农村艾滋病病毒感染者提供新的艾滋病毒服务提供模式
改善艾滋病毒连续护理并实现病毒抑制。传统治疗师 (TH) 是非专业提供者
他们充当非洲农村医疗保健的第一线,经常为患有以下疾病的艾滋病毒感染者提供护理
脱离艾滋病毒护理。 TH 是农村社区中平易近人且值得信赖的成员,但尚未被
纳入艾滋病毒护理计划。我们之前的整群随机试验表明,与 TH 的合作伙伴关系
通过促进艾滋病毒咨询和自我检测,乌干达农村地区艾滋病毒检测的普及率翻了两番。
基于这些结果,我们采用了基于证据的非专业提供者干预措施,由乌干达 TH 进行交付
支持艾滋病毒连续体的后续步骤。 TH 提供的程序称为 Omuyambi(“支持”
在 Runyankole),包括协助 PLWH 与 ART 启动护理联系起来,提供持续的咨询
坚持 ART,并鼓励保留临床护理。我们对这个非专业提供者进行了试点研究
该计划针对 12 名 TH 和 20 名 PLWH,他们没有接受过 HIV 护理或未接受过 ART。结果是
绝大多数积极:100% 的感染者与艾滋病毒护理相关,并在 14 天内开始抗逆转录病毒治疗,95% 报告称
9 个月后,ART 依从性和 100% 保持在护理状态。根据这些证据,我们
假设 TH 可以支持临床护理并改善农村 PLWH 的病毒抑制。我们
将进行混合 I 型有效性实施集群随机试验来评估有效性
Omuyambi 对乌干达未接受过抗逆转录病毒治疗/默认感染者进行病毒抑制的干预措施。
• 目标 1:在集群中比较 Omuyambi 干预措施与常规 HIV 诊所护理(对照)
随机试验。包括 ≥650 名 PLWH 的 40 个 TH 集群将被随机分配到 Omuyambi 干预组
或对照组,TH 将把 PLWH 转介至仅基于临床的 HIV 护理。主要临床结果是
通过干血斑分析测量 12 个月时的病毒抑制情况。我们假设 80% 的 PLWH
干预组将实现病毒抑制,而对照组为 60%。
• 目标 2:使用收敛混合方法研究设计和评估 Omuyambi 的实施情况
实施研究综合框架(CFIR)。定性和定量数据将
从参与的 TH、PLWH、HIV 诊所工作人员和卫生部官员收集。这些数据将被使用
评估 Omuyambi 实施的决定因素和结果。
拟议的研究意义重大,因为它响应了世界卫生组织和乌干达卫生部的要求
卫生部门呼吁以社区为基础的干预措施,以改善艾滋病病毒抑制,目前的计划
有次优的影响。如果有效,这种方法有可能改善农村地区艾滋病毒的连续性
艾滋病毒感染者达到结束艾滋病毒流行所需的联合国艾滋病规划署 95-95-95 基准。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Radhika Lu Sundararajan其他文献
Radhika Lu Sundararajan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Radhika Lu Sundararajan', 18)}}的其他基金
Expanding HIV testing among Ugandan adults who utilize traditional healers
在使用传统治疗师的乌干达成年人中扩大艾滋病毒检测范围
- 批准号:
9811818 - 财政年份:2018
- 资助金额:
$ 67.93万 - 项目类别:
Expanding HIV testing among Ugandan adults who utilize traditional healers
在使用传统治疗师的乌干达成年人中扩大艾滋病毒检测范围
- 批准号:
10401073 - 财政年份:2018
- 资助金额:
$ 67.93万 - 项目类别:
Expanding HIV testing among Ugandan adults who utilize traditional healers
在使用传统治疗师的乌干达成年人中扩大艾滋病毒检测范围
- 批准号:
9349310 - 财政年份:2017
- 资助金额:
$ 67.93万 - 项目类别:
相似海外基金
Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
- 批准号:
10568717 - 财政年份:2023
- 资助金额:
$ 67.93万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10419967 - 财政年份:2022
- 资助金额:
$ 67.93万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10592441 - 财政年份:2022
- 资助金额:
$ 67.93万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10369750 - 财政年份:2021
- 资助金额:
$ 67.93万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10633248 - 财政年份:2021
- 资助金额:
$ 67.93万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10487516 - 财政年份:2021
- 资助金额:
$ 67.93万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
10228564 - 财政年份:2018
- 资助金额:
$ 67.93万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
9347041 - 财政年份:2017
- 资助金额:
$ 67.93万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9480702 - 财政年份:2016
- 资助金额:
$ 67.93万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9906853 - 财政年份:2016
- 资助金额:
$ 67.93万 - 项目类别:














{{item.name}}会员




